Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Zillow Group Inc Class C — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B), while Zillow Group Inc Class C trades at $28.12 (market cap $6.42B). The key difference: Zillow Group Inc Class C is the larger of the two by market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Zillow Group Inc Class C nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Zillow Group Inc Class C for 39 Days on average.
| ORKA | Z | |
|---|---|---|
Market Cap | $5.08B | $6.42B |
Volume | 685,276 | 4,619,533 |
Sector | Health | Media |
52-Week High | $113.08 | $78.04 |
52-Week Low | $26.19 | $27.13 |
Typical Hold Time | 0 Days | 39 Days |
Enterprise Value | $4.21B | $6.29B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zillow Group (Z) trades at $27.97, up 0.47% on the day, but remains in a bearish technical trend with weak moving averages. The company shows improving fundamentals with revenue growing from $2.2B in 2024 to $2.6B in 2025 and net income turning positive at $23M. Recent earnings show mixed results with Q1 and Q2 2026 beats but a Q4 2025 miss. The stock faces headwinds from elevated mortgage rates and housing market softness, though analyst consensus remains optimistic with a $52 price target.
Zillow presents a turnaround story with profitability improving but faces significant housing market risks. The stock trades at a premium valuation (P/E 123) despite modest margins, suggesting high growth expectations. Analyst sentiment is mixed with 46% buy ratings but technical indicators signal caution. Key catalysts include AI integration and rental platform expansion, while risks include mortgage rate sensitivity and competitive pressures from Compass.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
